http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Hyunyou Kim ),( Nuri Lee ),( Sung Pil Yun ),( Hyung-il Seo ),( Myunghee Yoon ) 대한간학회 2018 춘·추계 학술대회 (KASL) Vol.2018 No.1
Aims: The alpha fetoprotein(AFP) elevation in hepatocellular carcinoma(HCC) has been shown to correlate with poor tumor differentiation, early intrahepatic recurrence after a hepatectomy. We aimed to examine the AFP levels, tumor burden, histologic grade, and other clinicopathological variables compare with two groups of HCC patients either with low or high AFP. This comparison helps us to predict intrahepatic recurrence of HCC. Methods: We retrospectively reviewed medical records of HCC patients who received hepatectomy between January 2009 and December 2015. Perioperative data were collected from the patients. Results: Of 181 recipients, we divided two groups either with low or high AFP. Histological variables were analyzed with serum AFP. We observed intrahepatic recurrence rates, disease free survival, and 3years/5years overall survival rates for 7years. Conclusions: In high AFP and poorly differentiated HCC patients had early intra-hepatic recurrence and low survival rates. Prospective study for AFP genes of HCC patients would be planned.
Hyunyou Kim,So Jeong Lee,Myunghee Yoon 대한외과학회 2020 Annals of Surgical Treatment and Research(ASRT) Vol.98 No.4
Purpose: Intrahepatic recurrence has a significant effect on the survival of hepatocellular carcinoma (HCC) patients. We aimed to determine if there are useful indicators in predicting the recurrence of liver cancer after a hepatic resection. Methods: We retrospectively reviewed medical records of 210 HCC patients who underwent hepatectomy between January 2009 and December 2015. We examined clinic-pathological variables comparing 2 groups of HCC patients, either intrahepatic recurrence or not. Results: We divided 184 patients into 2 groups; 94 patients (51.1%) with intrahepatic recurrence and 90 patients (48.9%) without intrahepatic recurrence. Multivariate analysis showed operation type, preoperative α-FP, postoperative protein induced by vitamin K absence-II (PIVKA-II) elevation, and multiple tumor number were closely associated with intrahepatic recurrence. The preoperative PIVKA-II level was not statistically significant in postoperative intrahepatic recurrence rate. The recurrence rate was 46.2% in 132 of 184 cases of α-FP < 100 ng/mL group. Of the 184 cases, α-FP 100–200 ng/mL were 14 cases (12 cases recurred (85.7%)). Alpha-fetoprotein > 200 ng/mL was 38 of 184 cases, 21 of which recurred (55.3%). According to the multivariate analysis, OR ratio was 8.003 (95% confidence interval [CI], 1.549–41.353) in the α-FP 100–200 ng/mL group and 1.867 (95% CI, 0.784–4.444) in α-FP 200 ng/mL or higher group (P = 0.013). Three-year survival rate of intrahepatic recurrence patients was 80.7%, 3-year survival rate of no intrahepatic recurrence patients was 95.0%. Conclusion: The intrahepatic recurrence rates were high in the group preop α-FP over 100 ng/mL. Close observation is needed. Prospective study for α-FP genes of HCC patients should be planned for predicting intrahepatic recurrence after hepatectomy.
Hepatic resection for isolated stomach cancer liver metastases: A single-center experience
Hyunyou Kim,Hyung-Il Seo 대한종양외과학회 2019 Korean Journal of Clinical Oncology Vol.15 No.2
Purpose: The objective of this study was to investigate the outcomes of selected patients with stomach cancer liver metastasis (SCLM) without extrahepatic metastases after hepatic resection. Methods: Patients whose imaging results did not detect extrahepatic disease were selected for hepatic resection. If R0 resection was possible and if the operative risk was low in the preoperative tests, the patients underwent hepatic resection. Results: Between 2011 and 2016, seven patients underwent hepatic resection for SCLM. All patients received hepatic resection to achieve an R0 resection. Minor liver resection was performed in all patients. Two patients showed long-term survival with a single lesion and human epidermal growth factor receptor 2 (HER2)-negative tumor. The 5-year overall survival and disease-free survival rates after hepatic resection were 38.1% and 28.6%, respectively. Conclusion: Hepatic resection for isolated SCLM may be considered as a multimodality treatment. However, it has only limited benefits in select patients. It has long-term survival benefit in patients with single metastases and HER2-negative hormonal status.